Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 1
1974 2
1975 1
1976 2
1978 2
1981 1
1984 2
1986 1
1987 2
1988 2
1989 2
1991 1
1992 2
1993 1
1994 2
1995 2
1996 1
1997 3
1998 4
1999 1
2000 4
2001 2
2002 1
2004 3
2005 3
2006 5
2007 5
2008 9
2009 3
2010 8
2011 8
2012 4
2013 10
2014 13
2015 7
2016 5
2017 3
2018 4
2019 5
2020 4
2021 5
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Antigen-specific active immunotherapy for ovarian cancer.
Paijens ST, Leffers N, Daemen T, Helfrich W, Boezen HM, Cohlen BJ, Melief CJ, de Bruyn M, Nijman HW. Paijens ST, et al. Among authors: helfrich w. Cochrane Database Syst Rev. 2018 Sep 10;9(9):CD007287. doi: 10.1002/14651858.CD007287.pub4. Cochrane Database Syst Rev. 2018. PMID: 30199097 Free PMC article. Review.
Ou-Yang and Helfrich reply.
Zhong-can OY, Helfrich W. Zhong-can OY, et al. Among authors: helfrich w. Phys Rev Lett. 1988 Sep 12;61(11):1326. doi: 10.1103/PhysRevLett.61.1326. Phys Rev Lett. 1988. PMID: 10038764 No abstract available.
EpCAM-targeted induction of apoptosis.
Bremer E, Helfrich W. Bremer E, et al. Among authors: helfrich w. Front Biosci. 2008 May 1;13:5042-9. doi: 10.2741/3062. Front Biosci. 2008. PMID: 18508568 Review.
Antigen-specific active immunotherapy for ovarian cancer.
Leffers N, Daemen T, Helfrich W, Boezen HM, Cohlen BJ, Melief CJ, Nijman HW. Leffers N, et al. Among authors: helfrich w. Cochrane Database Syst Rev. 2014 Sep 17;(9):CD007287. doi: 10.1002/14651858.CD007287.pub3. Cochrane Database Syst Rev. 2014. PMID: 25229990 Updated. Review.
Therapeutic potential of Galectin-9 in human disease.
Wiersma VR, de Bruyn M, Helfrich W, Bremer E. Wiersma VR, et al. Among authors: helfrich w. Med Res Rev. 2013 Jun;33 Suppl 1:E102-26. doi: 10.1002/med.20249. Epub 2011 Jul 26. Med Res Rev. 2013. PMID: 21793015 Review.
Antigen-specific active immunotherapy for ovarian cancer.
Leffers N, Daemen T, Helfrich W, Boezen HM, Cohlen BJ, Melief K, Nijman HW. Leffers N, et al. Among authors: helfrich w. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007287. doi: 10.1002/14651858.CD007287.pub2. Cochrane Database Syst Rev. 2010. PMID: 20091627 Updated. Review.
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR.
Ploeg EM, Samplonius DF, Xiong X, Ke X, Hendriks MAJM, Britsch I, van Wijngaarden AP, Zhang H, Helfrich W. Ploeg EM, et al. Among authors: helfrich w. J Immunother Cancer. 2023 Sep;11(9):e006837. doi: 10.1136/jitc-2023-006837. J Immunother Cancer. 2023. PMID: 37734877 Free PMC article.
143 results